Measurement of Basal, Substrate Induced and Total P-Glycoprotein Activity in Bronchoalveolar Lavage T-Cell Subsets

Cytometry Part A

Volumn 57, Issue 2, 2004, Pages 75-85

  Donnenberg, V S ^a   Wilson, J W ^b   Burckart, G J ^c   Zeevi, A ^a   Iacono, A ^a   Donnenberg, A D ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Bronchoalveolar lavage; Dye efflux; Multiple drug resistance pump; P glycoprotein; Rhodamine 123; T cells

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; DYE; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; LUNG LAVAGE; LUNG TRANSPLANTATION; MONONUCLEAR CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 1042268027     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.10114     Document Type: Article

References (20)

1. Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V, Riordan JR. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophy Res Commun 1986;141:956-962.
2. Ling V, Thompson LH. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 1974;83:103-116.
3. Ling V, Kartner N, Sudo T, Siminovitch L, Riordan JR. Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep 1983;67:869-874.
4. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992;80:2735-2739.
5. Ward C, Whitford H, Snell G, Bao H, Zheng L, Reid D, Williams TJ, Walters EH. Bronchoalveolar lavage macrophage and lymphocyte phenotypes in lung transplant recipients. J Heart Lung Transplant 2001;20:1064-1074.
6. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
7. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;99:507-512.
8. Ludescher C, Eisterer W, Hilbe W, Hofmann J, Thaler J. Decreased potency of MDR-modulators under serum conditions determined by a functional assay. Br J Haematol 1995;91:652-657.
9. Pallis M, Turzanski J, Harrison G, Wheatley K, Langabeer S, Burnett AK, Russell NH. Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia. Br J Haematol 1999;104:307-312.
10. De Moerloose B, Dhooge C, Laureys G, Benoit Y, Demarche M, Devalck C, Plantaz D, Leroy J, Philippe J. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors. Cytometry 1999;37:125-132.
11. Huet S, Marie JP, Gualde N, Robert J. Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network. Cytometry 1998;34:248-256.
12. Donnenberg VS, Burckart GJ, Griffith BP, Jain AB, Zeevi A, Donnenberg AD. P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients. J Clin Pharmacol 2001;41:1271-1279.
13. Vredenburg MR, Ojima I, Veith J, Pera P, Kee K, Cabral F, Sharma A, Kanter P, Greco WR, Bernacki RJ. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. J Natl Cancer Inst 2001;93:1234-1245.
14. Elbling L, Berger W, Weiss RM, Printz D, Fritsch G, Micksche M. A novel bioassay for P-glycoprotein functionality using cytochalasin D. Cytometry 1998;31:187-198.
15. Udomsakdi C, Eaves CJ, Sutherland HJ, Lansdorp PM. Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp Hematol 1991;19:338-342.
16. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39:361-398.
17. Donnenberg VS, Calhoun W, Burckart GJ, Wilson JW, Donnenberg AD. P-glycoprotein (P-gp) activity is upregulated in human T cells isolated from lungs of healthy volunteers. 13th Annual Meeting, American College of Clinical Pharmacology, Vienna, VA; September 2001. J Clin Pharmacol 2001;41:1024.
18. Web M, Raphael CM, Asbahr H, Erber WN, Meyer BF. The detection of rhodamine 123 efflux at low levels of drug resistance. Br J Haematol 1996;93:650-655.
19. Krishan A, Fitz CM, Andritsch I. Drug retention, efflux, and resistance in tumor cells. Cytometry 1997;29:279-285.
20. Ludescher C, Pall G, Irschick EU, Gastl G. Differential activity of P-glycoprotein in normal blood lymphocyte subsets. Br J Haematol 1998;101:722-727.